111
Views
5
CrossRef citations to date
0
Altmetric
Miscellaneous

Pharmacotherapy of intermittent claudication

Pages 1725-1736 | Published online: 24 Feb 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Melville Q. Wyche, Elliott Perlin, Richard M. Millis, Masoud Nahavandi & Fatemeh Tavakkoli. (2003) Arterialization of Venous Blood for Differentiation of Sickle Cell Subjects in Vaso-occlusive Crisis. Hematology 8:6, pages 421-428.
Read now
Sheila A Doggrell. (2003) The role of 5-HT on the cardiovascular and renal systems and the clinical potential of 5-HT modulation. Expert Opinion on Investigational Drugs 12:5, pages 805-823.
Read now

Articles from other publishers (3)

Kousaku Ohno, Atsuyuki Tomizawa, Makoto Mizuno, Joseph A. Jakubowski & Atsuhiro Sugidachi. (2016) Prasugrel, a Platelet P2Y 12 Receptor Antagonist, Improves Abnormal Gait in a Novel Murine Model of Thrombotic Hindlimb Ischemia . Journal of the American Heart Association 5:4.
Crossref
B. Brenner, J. T. Harney, B. A. Ahmed, B. C. Jeffus, R. Unal, J. L. Mehta & F. Kilic. (2007) Plasma serotonin levels and the platelet serotonin transporter. Journal of Neurochemistry 102:1, pages 206-215.
Crossref
AW Bradbury. (2003) THE ROLE OF CILOSTAZOL (PLETAL ™ ) IN THE MANAGEMENT OF INTERMITTENT CLAUDICATION . International Journal of Clinical Practice 57:5, pages 405-409.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.